Bexsero Short Course (Men B) – Elearning

Our Men B Short Course is part of the Health Academy Short Course series and gives clinicians the essential immunisation knowledge needed to safely and confidently deliver the MenB (Bexsero®) vaccine in the UK. This focused e-learning programme covers meningococcal B disease, risk groups, vaccine indications, administration considerations, and current UK guidance, making it ideal for anyone involved in MenB vaccination.

image showing bexsero product in packet

What You'll Learn

  • Understand how meningococcal B disease develops, how it spreads, and which groups are most at risk.
  • Recognise the clinical features of MenB disease and understand its potential complications, including sepsis and meningitis.
  • Apply UKHSA-aligned guidance on Bexsero® vaccination, including eligibility, schedules, precautions, administration, and patient counselling.

This course includes

Videos

Case Studies

Quizzes & Assessments

Course Content

  • Overview of course structure and learning objectives
  • Organism overview (Neisseria meningitidis, serogroup B)
  • Transmission and carriage
  • Epidemiology and high-risk populations
  • Clinical presentation
  • Complications and long-term impacts
  • Public health importance and prevention
  • Current UK recommendations for use
  • Eligibility groups: routine childhood programme, clinical risk groups, catch-up situations
  • Dosing schedules and spacing
  • Contraindications, precautions, and co-administration
  • Administration guidance, storage, and handling
  • Expected adverse reactions (including post-vaccination fever in infants) and how to advise parents/carers
  • Links to UKHSA guidance, the Green Book, and national immunisation updates
  • Multiple-choice assessment to consolidate learning and confirm competence

FAQs

Yes, you will receive a certificate on successful completion of the course.

  • Assessment is completed through integrated quizzes and a final online assessment.

This course follows UKHSA and national immunisation guidance. To administer MenB vaccinations, clinicians must have completed a foundation immunisation training course, undertake supervised practice in their workplace, and should only administer vaccines independently when both they and their employer are confident in their competence.

Leave Us A Review

Description

This is part of the ‘Health Academy Short Course’ series and provides clinicians with specific information related to the Bexsero vaccine.

This course is suitable for all Registered Healthcare Professionals, including Nurses, Pharmacists and GPs that administer this vaccine in practice.

The course will cover key details of the vaccine and the diseases that it protects against.

Bexsero is a Meningococcal group B Vaccine.

Bexsero contains four different components from the surface of the bacteria Neisseria meningitidis

group B.

Bexsero is given to individuals from 2 months of age and older to help protect against disease caused

by the Neisseria meningitidis group B bacteria. These bacteria can cause serious, and sometimes

life-threatening, infections such as meningitis (inflammation of the covering of the brain and spinal

cord) and sepsis (blood poisoning).

The vaccine works by specifically stimulating the body’s natural defense system of the vaccinated

person. This results in protection against the disease.

The course provides 1 hour of CPD

Group booking - click for discounted rates

Reviews

There are no reviews yet.

Be the first to review “Bexsero Short Course (Men B) – Elearning”
E-learning

Professional Certificate

Gain up-to-date, practical knowledge of MenB disease and Bexsero® vaccination in line with current UK immunisation recommendations.

E-learning self paced course

£22.80

1

CPD Hours

Register Your Interest